Europe Women’s Digital Health Market

Europe Women’s Digital Health Market Analysis

The Europe women's digital health market   is valued at USD 0.73 billion in 2024 and this value is anticipated to reach USD 4.8 billion by 2035. The market has been projected to grow at a compounded annual growth rate (CAGR) of 17.9% during the forecast period.

To learn more about this report, request a free sample copy

Given the progress in advanced technology to maintain reproductive health, the Europe women's digital health market is experiencing an upward trajectory. The growth can be attributed to the aging population and increasing prevalence of women associated with health diseases in Europe and other regions. The ongoing risk of diseases among women has surged the demand for remote monitoring and digital health tracking devices that help in early diagnosis and treatment planning. According to the World Health Organization report, in recent years, there is a significant increase in the adoption of digital health monitoring devices and solutions across WHO European region, revolutionizing the way patients receive treatment at healthcare facilities, remote areas and clinics. In order to support the growing adoption of digital health technologies for managing women's health, several industrial leaders and government organizations increased their investment in this field. For instance, the Femtech startup companies in Europe successfully raised over USD 161 million in 2022 focusing on the development of women's health applications and solutions. The funding has been done across different digital health market segments including R&D, services testing, innovation and deployment of devices / services in different regions of Europe.

To date, healthcare systems continue to adapt digital therapeutics  including digital software, devices and technology solutions to address women's health issues other than reproduction. The primary goal of using women's digital health technology or encouraging females to use digital solutions is to manage diseases at an early stage in a responsible manner. Furthermore, the growing awareness among women about digital technologies and their role in resolving reproductive health issues has resulted in the widespread adoption of these innovative solutions. Driven by the increasing usage, various industrial leaders active in Europe women's digital health market have increased their efforts to develop new products. Additionally, various industrial and non-industrial organizations are increasing their investment activities to improve healthcare infrastructure in European countries.

Europe Women’s Digital Health Market Segmentation Insights

Below listed table provides the in-depth analysis across different segments of women’s digital health market study report. 

Europe Women’s Digital Health Market: Report Attributes / Market Segmentations

The detailed analysis of the Europe women's digital health market has been done to provide stakeholders robust information about primary growth drivers, market restraints, trends and opportunities emerging in the field. This report covers detailed information about the evolution of the Europe women’s digital health market for the period 2024-2035. We have provided year-wise projections of the current market and future opportunities across different segments as mentioned in the table above. 

In order to provide a robust study model and context about future uncertainties, we have provided three market forecast scenarios, namely conservative, base and optimistic scenarios, representing industrial growth trends. 

All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this report are in USD unless otherwise specified.

Europe Women’s Digital Health Market Share Insights

Market Share by Type of Solutions

Based on the type of solutions, the Europe women’s digital health market is distributed across Applications / Software, Devices, and Services. The women’s reproductive health market witnessed steady growth in different European countries. According to our projection, the reproductive health / fertility application adoption rate in France is projected to be USD 326.4 million by 2035. The growth can be attributed to the increasing usage of software and applications to manage reproductive health in women. 

Market Share by Type of Application Area

The opportunity in Europe women’s digital health market is distributed across reproductive health / fertility, menstrual cycle, general wellness, pelvic care and other therapeutic areas. In terms of application areas, there are several apps, devices and services developed by industrial leaders for tracking and monitoring reproductive health. Based on the apps, with a target women population of 2.77 million, the adoption rate of reproductive health / fertility apps in Germany is 20.8% in 2024. The trend of adoption is likely to remain unchanged owing to the increasing awareness about monitoring reproductive health for safe pregnancy. 

European Women’s Digital Health Market Dynamics 

The “Europe Women’s Digital Health Market: Distribution by Type of Solutions (Applications / Software, Devices and Services), Therapeutic Application Areas (Fetal Health, General Wellness, Menstrual Cycle, Pelvic Care, Reproductive Health / Fertility, and Other Therapeutic Areas), and European Countries (Germany, UK, France, Russia, Italy, and Rest of the World): Industry Trends and Regional Forecasts, Till 2035” is an in-depth report on status of European market within the global women’s digital health market. It features a dynamic study on current market landscape, and future scenarios, offering an informed opinion on the likely future potential of Europe based women's digital health solution providers, over the next decade. The study underlines an in-depth analysis, highlighting various industry stakeholders' diverse capabilities in this field.

Market Drivers Analysis: Rising Incidence of Chronic Diseases in Women 

The Europe women’s digital health market is driven by several factors; One of the significant factors driving growth in this field is increasing incidence of chronic conditions, infectious diseases and risk of cancer in women. According to a recent published report, breast cancer is the most widely occuring cancer in women within WHO European region, with projected incidence of 604,900 in 2022. Another report suggests that two third women in the UK experience menstrual issues during work. The growing cases of diseases has underscored the requirement of advanced technologies that help in monitoring diseases and reproductive health issues at an early stage. Further, a rapid increase in technological advances for the prevention of future women's reproductive and menstrual-associated diseases is likely to drive growth in Europe women's digital health market. Additionally, the increasing interest of industrial leaders for the development of innovative devices has become a major growth factor driving the market in the future.

Market Challenges: Complex Regulatory Guidelines 

Even though significant growth opportunities are driving the market, there are several factors that may impede its growth in the future. One of the possible market restraints is complex regulatory guidelines that may vary according to different European countries. Further, digital health technologies and applications involve usage of the internet of things for exchanging data across different healthcare networks. The data transfer through software applications may pose a risk of data breach. Security and data breaching activities are major concerns that have to be addressed by the key players in the women's digital health market for smoother data integration. Additionally, the high cost associated with the development of reproductive health and menstrual health devices, applications, and services may hinder the market growth during the forecast period. 

Market Trends Analysis: Shift Towards Remote Monitoring Devices and Telehealth Services 

Given the increasing adoption of applications, devices and services to maintain women's reproductive health, the European women's digital health market is experiencing substantial growth. Presently, industrial leaders are emphasizing the development of innovative apps, devices, and service solutions for the maintenance of women's reproductive health. Technological innovations cover a wide range of applications, including applications for menstrual cycle monitoring and reproductive health / fertility apps. 

According to our projection, the reproductive health / fertility app market in France is estimated to be worth 51.31 million in 2024. Owing to the increasing adoption of these technologies in different countries, the demand for specialized digital healthcare applications, devices, and services has increased. It is worth noting here that various industrial leaders enter into the collaboration to increase their efforts to develop technology-based devices. Furthermore, the penetration of telehealth services, remote patient monitoring devices and integration of digital health technologies in women's reproductive health is anticipated to bring enormous opportunities to drive innovation in this industry within the European region.

Europe Women’s Digital Health Market Size

Europe women's digital health market is anticipated to be worth USD 0.73 billion in 2024. Driven by the widespread adoption of devices for monitoring women's health parameters, the female reproductive health / fertility health device market in Europe is anticipated to hold 30% of the overall revenue share by 2035. The reproductive health / fertility health device market is projected to grow at a CAGR of 20.6% during the forecast period. 

Europe Women’s Digital Health Market (Services Analysis)

The market research report covers a detailed analysis of the Europe women's digital health market across major countries covered under this region. According to our projection, the women's digital health market is currently focused on bringing technological advancements for managing women’s reproductive health in regions such Germany, France, the UK, Russia and Italy. Owing to the increasing demand for reproductive health services, the services market is estimated to be distributed among different therapeutic applications, including menstrual cycle, reproductive health / fertility, general wellness, pelvic care, and fetal health. 
The services market in Europe is estimated to be around 0.017 billion in 2024. Based on the end users of services, currently patients will dominate the market, anticipated to hold 81% of the overall share of the market in 2024. 

Europe Women’s Digital Health Market Analysis (Based on Devices for General Wellness)

General wellness is the primary goal of healthcare experts to maintain women's reproductive health. In recent years, the global women population has experienced general health issues that include hypertension, depression, anxiety, and obesity. According to the World Health Organization, anxiety and depression among adolescent girls in Europe are a significant concern. Further, the report of the European Union predicts that one out of five women in Europe is overweight, and 15% are underweight - the increasing risk of general health issues among women necessitates the development of devices to maintain general wellness. According to our projection, the penetration of general wellness devices in France and increasing awareness among women is estimated to grow the device market in the future. The general wellness device market in France is estimated to be 1.6 million and is expected to grow during the forecast period. 

Key Companies in the Europe Women's Digital Health Market

Examples of key companies engaged in the Europe women's digital health industry (which have also been profiled in this market report; the complete list of companies is available in the full report) include:

• Ava Women
• Braster 
• Clue by Biowink
• Elvie
• Natural Cycles

This Europe women's digital health market report includes an easily searchable Excel database of all the companies providing women's digital health products worldwide.

Recent Developments in Europe Women's Digital Health Market

Several recent developments have taken place in women's digital health in Europe. We have outlined some of these recent initiatives below. These developments, even if they took place post the release of our market report, substantiate the overall market trends outlined in our analysis.

• In April 2026, the European Commission launched €63.2 million in funding calls under the Digital Europe Programme, including €24.4 million for digital health systems and €9 million for AI-powered medical screening. These initiatives supported the development of data-driven healthcare services, including applications relevant to women’s health, under the European Health Data Space framework.
• In March 2026, Berlin-based Remi Health raised €3 million in seed funding, reaching €5 million in total, to expand its diagnostics-as-a-service platform across Europe. The infrastructure supported at-home and decentralized testing, enabling femtech companies to scale services such as fertility, hormone, and microbiome testing across fragmented European healthcare systems.
• In March 2026, DocMorris partnered with Google to enhance its AI-driven digital health platform across Europe by integrating advanced cloud and AI capabilities. The collaboration aimed to improve patient journeys through connected digital services, with potential applications across therapeutic areas including women’s health, supporting broader adoption of personalized and technology-enabled care delivery.
• In March 2026, the Île-de-France Region announced the launch of a €50 million “Femtech Île-de-France” investment fund, managed by Turenne Santé with scientific backing from Université Paris Cité. The initiative aimed to accelerate innovation in women’s health across life stages, addressing gender health gaps and supporting startups and digital health solutions within Europe’s femtech ecosystem.
• In March 2026, Belgium-based Uma Health raised €750,000 in growth capital from angel investors and institutional partners, including imec.istart and PMV. The funding supported expansion of its digital women’s health platform, development of new services, and international scaling, strengthening Europe’s femtech ecosystem and digital care delivery targeting female-specific health conditions.
• In January 2026, UK-based Evaro secured €21 million in Series A funding led by AlbionVC to expand its NHS-licensed digital healthcare platform, including women’s health services. Partnerships with Clue and Lovehoney enabled embedded prescription services within consumer apps, supporting integrated digital care delivery and scaling women’s digital health offerings across European markets.